TNF and inflammatory bowel disease: Their model covers disease duration, endoscopic Mayo Score, steroid use and dose, TNF-alpha inhibitor use, and the site of disease involvement.21D In a different manner, the present study attempted to propose a model to be used not only for patients with IBD but also for other patient groups in the entire cohort, which may be considered the hallmark of this study.